chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache, fever, "red upper arm and upper arm swelling"   "Rash on her back (which may have been caused by sunblock she used the day before). "Rash not associated with vaccines".
MMR AND VARICELLA VACCINES WERE GIVEN ON THE LEFT THIGH. 15 MINUTES AFTER, SMALL RED BUMPS NOTICED ON THE AREA. PATIENT AND PARENTS WERE ESCORTED TO ER AR PER D.R. RINCIOAGA-HUHULEA'S INSTURCTIONS
Arm was very sore for 3 days on the 2nd day after taking the vaccine.
itchy all over her body; a little bit of hives; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy all over her body) and URTICARIA (a little bit of hives) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013MZ0A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and COLECALCIFEROL, MENAQUINONE-7, PHYTOMENADIONE, RETINOL PALMITATE, TOCOPHEROL, TOCOTRIENOLS NOS (VITAMIN D COMPLEX) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced PRURITUS (itchy all over her body) and URTICARIA (a little bit of hives). At the time of the report, PRURITUS (itchy all over her body) and URTICARIA (a little bit of hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment was provided.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded.
10/19/21 call to clinic stating tingling, numbness all over body, body aches, fatigue, fever, chest tightness and intermittent palpitations. 10/20/21 Office Visit Note below Friday got first dose of covid vaccine, states she is feeling off since then.  Was fine for the first couple of hours but then 3 hours later started feeling drained, tired, arm was throbbing. As the days went on she has noticed more and more symptoms. Got chills, felt as though face was on fire. 101.5F, alternating tylenol and ibuprofen. This morning when she woke up this morning had a fever and took ibuprofen.  Bilateral groin tenderness started Saturday/sunday. Gets weird numbness and tingling throughout body.  Palpitations started Friday night. Every 2 hours, lasts 5-10 minutes. Slightly some shortness of breath and "slightly" some chest pain with it.    Currently legs are sore, hard to walk because of the pain, elevates her legs because of the swelling. No noted redness. Swelling is new to her legs. No prior history of this. Notices sock line. This does improve once she elevates her legs but then as soon as she gets up again notices the swelling. Legs are bothering her the most with the leg swelling.  Face feels hot but fingers and hands are freezing. Neck is also sore.    Has been off of work due to her fevers and symptoms.  No prior history of PEs. Has Mirena IUD in place.  10/21/21: Presents to ED, see notes below, still in ED at time of this form HPI The patient is a 35 year old female with a history of asthma who presents to the Emergency Department with a chief complaint of left leg pain. The patient received the first dose of the Pfizer COVID-19 vaccine on 10/15/2021 and states that she has been feeling "off" since. She was evaluated at the Respiratory Clinic yesterday for fatigue, fevers, chills, shortness of breath, chest tightness, and leg swelling and pain. A bilateral lower extremity ultrasound, CT angio of the chest, and labs were obtained. Findings were significant for a single subsegmental PE. Patient was contacted today with CT scan findings and was recommended to come into the Emergency Department for further evaluation of symptoms. The patient states that she woke up this morning with increased left anterior thigh pain and an acute onset of left sided abdominal pain. Notes that the pain work her up from her sleep this morning. Her left thigh pain is currently rated as a 7/10 in severity and described as aching with no radiation. No other associated symptoms noted. Symptoms are aggravated with palpation and movement of the left lower extremity and there are no alleviating factors. The patient denies nausea, vomiting, chest pain, back pain, head pain, dizziness, or lightheadedness. She denies taking any medications prior to arrival. No other reported symptoms at this time.
pt recv vax 16JAN97 & 31JAN97 noticed swelling to both knee joints & aching of hands & feet; 2 small areas of swelling approx 1/4" noted behind ears;1FEB97 macular rash, Pruritic;swelling of knees & aching of joints;
Pain at immunization site which expanded approx. 10 cm proximally & distally, lasted 2 weeks.  No signs secondary infection.  Rx'ed with NSAIDS, supportive measures.
shingles; Information has been received from a lawyer regarding a case in litigation and refers to a patient (pt) of unknown age and gender. No information was provided regarding medical history, concurrent conditions and concomitant medications. In 2011, the pt was vaccinated by healthcare providers with zoster vaccine live (ZOSTAVAX) (lot number, expiration date, dose and route of administration were not provided) for the long-term prevention of shingles and zoster-related conditions. Subsequent to zoster vaccine live (ZOSTAVAX) inoculation, the pt was treated by healthcare providers for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccination, the pt suffered and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of shingles was not recovered. The reporter considered shingles to be related to zoster vaccine live (ZOSTAVAX).
bump has gone but is blue and black and looks like an old spider bite; sinus infection; flehm in her throat; like a small mosquito bite at the injection site/bump started to grow1 week later; itchy; entire arm tingled; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (bump has gone but is blue and black and looks like an old spider bite), SINUSITIS (sinus infection), PARAESTHESIA (entire arm tingled), PRODUCTIVE COUGH (flehm in her throat) and PRURITUS (itchy) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis and Allergy NOS. Concomitant products included CEFIXIME (FLEXERIL [CEFIXIME]) and CELECOXIB (CELEBREX) for Arthritis, IRON and OMEGA-3 NOS for an unknown indication.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced PARAESTHESIA (entire arm tingled) and PRURITUS (itchy). On 15-May-2021, the patient experienced VACCINATION SITE SWELLING (like a small mosquito bite at the injection site/bump started to grow1 week later). On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (bump has gone but is blue and black and looks like an old spider bite), SINUSITIS (sinus infection) and PRODUCTIVE COUGH (flehm in her throat). The patient was treated with Manual therapy (Cold compress) for Paraesthesia and Manual therapy (Cold compress) for Pruritus. At the time of the report, VACCINATION SITE DISCOLOURATION (bump has gone but is blue and black and looks like an old spider bite), SINUSITIS (sinus infection), PARAESTHESIA (entire arm tingled), PRODUCTIVE COUGH (flehm in her throat), PRURITUS (itchy) and VACCINATION SITE SWELLING (like a small mosquito bite at the injection site/bump started to grow1 week later) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided by reporter.
Information has been received from a physician who reported that a mother chose to stop her daughter's GARDASIL due to "bad press". The article was in the newspaper concerning three girls, who had experiences after receiving the vaccine. On an unspecified date the patient who was vaccinated with a dose of GARDASIL (lot # not reported). On an unspecified date she experienced charley horse, spasms and pain in muscles with fainting, nausea, irregular heartbeat and rash since she received GARDASIL. The patient's outcome was not reported. This is one of three reports from the same source. No additional information is available.
This patient was in clinic for a primary care visit, with her mother, and decided to receive her 1st dose of Pfizer. The clinic assistant that administered the vaccine  accidentally prepared the vaccine with 0.18 mL of diluent (as opposed to the required 1.8 mL) and then proceeded to administer 0.3 mL of this concentrated preparation. This resulted in  the patient receiving a higher-than-authorized dose of Pfizer-- just under 6 doses. This error was caught within a few minutes after administration because a different staff member was drawing up a dose of Pfizer from that vial and realized there was not enough left in the vial, even though only 1 dose was recorded on the vial. This staff member immediately realized there was likely an error in the preparation and informed me. I had the staff member that prepared the vaccine walk me through the process they used and we realized her error of only adding 0.18 mL of diluent.  Per CDC  COVID-19 Vaccine Administration Errors and Deviation guidelines, the patient and her mother were immediately notified  of the error and the potential for adverse side effects, a report was made internally, and another health authority was contacted to verify the correct way to enter the error in the system. The patient was  kept in office for observation for 30 minutes post vaccination. The mother of the patient and the patient asked to leave once the 30 minutes was up as the patient denied symptoms. One of our RNs is going to contact the patient tomorrow morning. The patient and mother were advised to call the clinic with any concerns and new symptoms. They were also given ED precautions.
pt states w/in 15 mins of receiving vax had ring of red bumps on lt forearm; states the next day & following days for the next 6months broke out w/red welts w/itching neck, chest, both arms, back axillae, & thighs, welts would come & go;
This spontaneous report as received from a physician refers to a female patient of unknown age with no pertinent medical history or drug allergies/reaction. On approximately an unspecified day in 2008 (reported as at age of 16 or 17 years of patient) the patient was vaccinated with the first dose of GARDASIL intramuscularly. And the patient was administered her second dose of GARDASIL an unspecified period time later. There was no concomitant therapy included. Subsequent to that second dose of GARDASIL, the patient was hospitalized (Dates of the three hospitalizations are unspecified) three times for joint pain, shortness of breath, chest pain, and overall fatigue and muscle aches which went away each time. About six weeks ago, approximately 14-FEB-2013 lesions were noted that had now been diagnosed as bullous pemphigoid". Patient sought medical attention and received treatment for adverse event but various things that had not worked. Biopsy result was pending. At the time of report the outcome of joint pain, shortness of breath, chest pain, and overall fatigue and muscle aches was recovered and bullous pemphigoid was unknown. Additional information has been requested.
felt pretty lousy; This is a spontaneous report from non-contactable Physician (patient) communicated to Pfizer Sales Representative. A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, expiration date: unknown), via an unspecified route of administration on an unspecified date as 2nd dose, single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included Covid-19 vaccine for covid-19 immunization. The patient experienced felt pretty lousy on an unspecified date, this event took place after taking vaccine. Took Tylenol 21 hours after vaccination and began to feel better. The patient recovered from the event on an unspecified date.  Follow up attempts are not possible. No further information is expected.
Itchy arms within 15 minutes of injection; itchiness spreading to neck and back and arms and legs for about an hour; itching subsided within an hour  Moderate muscle soreness at injection site began several hours after injection
Grandmother explained on 5/21/21 that pt had rare sickness called Panda disease that can lead to seizures, twitching, and tics. States pt had to go to ER in the evening after due to severe seizure onset, vomiting, and increased swelling in injection site.
The patient reported that he had a witnessed syncopal event - he was leaning against a wall and slid down the wall without head or other trauma. He recovered consciousness immediately thereafter. He did no check any vitals or blood sugar afterwards, and did not report the event until two days later, therefore no testing was done at the time of the event. There are no known sequelae.
Tinnitus volume has increased significantly and is now present in both ears. This started a day or two after recovering from the flu-like side effects.
sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An adult male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose 1, single, lot number unknown), for COVID-19 immunization, reaction(s): "sore arm". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300012926 same patient, events after different doses of the vaccine.
received third dose "booster" of vaccine during an office visit to her GP; received third dose "booster" of vaccine during an office visit to her GP; Experienced arm pain on injection arm.; This is a spontaneous report from a non-contactable consumer(patient) via a company representative. An 80-year-old female patient received third dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route in the arm on an unspecified date, at 80-year-old, as single dose(Batch/Lot number was not reported) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE),via an unspecified route of administration on an unspecified date, as single dose(Batch/Lot number was not reported) and second dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE),via an unspecified route of administration on an unspecified date, as single dose(Batch/Lot number was not reported) for covid-19 immunisation. The patient stated she received third dose "booster" of vaccine during an office visit to her general practitioner(GP) on an unspecified date. The patient experienced arm pain on injection arm. The outcome of Pain in arm was unknown.    Pfizer is a marketing authorization holder of Covid 19 Vaccination in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of Covid 19 Vaccination has submitted the same report to the regulatory authorities.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The next morning after receiving the vaccine I noticed that my mother she talking to me, as her primary giver she knows me and comfortable to me. She tells me the same story over the over with isn't abnormal. It was every 3-4 words she was jumbling her words. I didn't think anything of it at first. I just let it go.   Early Wednesday morning  2:48am, I heard her in her bedroom. I went to check on her, I found at her dresser trying to put her watch on. She didn't know who was I or didn't know where she was. It took me about 40 minutes to calm her down. Now it was every 2 words that she was jumbling up. I finally got her back to bed. I went to send a message to her doctor. In the morning someone from the doctor's office called back I explained what was going on and they said get her to an ER.   I took her to the hospital 01/27/2021.  She was admitted to hospital for overnight observation.  Still not been discharged. Patient was still confused when I had to left last night, did not understand where she was at or why she had to stay there. My mother was very angry when she woke up early Wednesday is not my mom she is very lovely. One year or two years she did have a TA or mini stroke.
Patient had 2nd met during a vaccine on 05/15/2021. That same evening into the next day noticed profound weakness with difficulty walking without assistance. Needed to be helped to bed last night. This morning woke up at baseline and feels completely normal with no weakness or fatigue. Never had any fevers, chills, nausea, vomiting, diarrhea. No dysphagia, aphasia, facial drooping noted.
This non-serious medically confirmed report (initial receipt 10-OCT-2014) concerns a female patient. On the 10-OCT-2014, the patient received AFLURIA (batch number not reported) 0.5 ml annually via the intramuscular route. The vaccine was expired on the 30-JUN-2014. It was believed that the patient was fine and had left the facility. Outcome was not reported.
Felt like I have been fighting off a headache, extremely sore arm and today (1/21/22) noticed the injection spot is red and maybe a little swollen.
Pt has an RX for; Bexsero Vaccine 2 doses; 1st dose on day 0 and 2nd dose on 1-2 months after day 0 MenACWY vaccine 2 doses; 1st dose on day 0 and 2nd dose on 8 weeks after day 0  Pt received the 1st doses of both vaccines (Bexsero and MenACWY) on 11/11/22. Unfortunately, home health agency RN went ahead and administered 2nd dose on Both vaccines (Bexsero and MenACWY) on 12/11/22. This makes the MenACWY 4 weeks earlier than it?s scheduled time (suppose to be around 1/5/23 8 weeks after the initial dose from 11/11/22). informed DR and asked him how he would like to proceed. I also called Dr. office this morning and spoke with someone and she asked me to send this in a fax. which I did. Pt has no adverse events that we are aware of.
Vaccine first dose on 28Feb2021; on 10Mar2021 she started developing COVID-19 symptoms, she then tested positive for COVID-19 infection on 19Mar2021; Vaccine first dose on 28Feb2021; on 10Mar2021 she started developing COVID-19 symptoms, she then tested positive for COVID-19 infection on 19Mar2021; This is a spontaneous report from a contactable pharmacist. A 40-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 28Feb2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that, Patient received Pfizer-BioNTech COVID-19 Vaccine first dose on 28Feb2021; on 10Mar2021 she started developing COVID-19 symptoms, she then tested positive for COVID-19 infection on 19Mar2021. Second dose is scheduled for next week. The pharmacist stated that the patient came in last night and asked if it is appropriate to get second dose. Outcome of the events was unknown.  Follow-up attempt completed, information about batch/lot number cannot be obtained.; Sender's Comments: The events drug ineffective and COVID-19 symptoms were considered probably related to suspect product.
Red wheals appeared on client's upper arm's and back approximately 10-15 minutes after receiving influenza vaccine in left deltoid. No complain of itching.
broke in hives; Initial information received on 20-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional via social media.  This case involves patient (unknown demographics) who experienced broke in hives (urticaria), when received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer and lot number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious broke in hives (urticaria) unknown latency following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown for urticaria.  There will be no information available on the batch number for this case.
Deep ache in arm began 4 days after injection.  Keep patient awake at night for several nights.  Felt like the feeling after hitting the funny bone - whole arm was affected.  Began to ease up 6 days after injection
Client report receiving second COVID vaccine on 04/12/2021 at 5:00 pm, adverse reaction began 1 to 2 days after of increased diarrhea, vomiting, coughing, wheezing, slight SOB, nose bleed, and migraine headache. Client has not contact his PCP as of yet, plan to if no improvement in symptoms.
Fever to 102.5, chills, sweating, tachycardia, muscle aches, fatigue which started  16 hours following vaccine.   These lasted about 12 hours, then resolved. Of note, I had mild COVID, 8 weeks prior to vaccine.